Citations
Key articles
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-2615.
Centers for Disease Control and Prevention. 2009 H1N1 early outbreak and disease characteristics.November 2009. http://www.cdc.gov/ (last accessed 8 November 2011).
Weinberg A, Song LY, Walker R, et al. Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children. J Acquir Immune Defic Syndr. 2010;55:189-196.
Talbot HK, Keitel W, Cate TR, et al. Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine. 2008;26:4057-4061.
Kohno S, Kida H, Mizuguchi M, et al. Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection. Antimicrob Agents Chemother. 2010;54:4568-4574.
Duval X, van der WS, Blanchon T, et al. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med. 2010;7:e1000362.
Reference articles
1. World Health Organization. Pandemic (H1N1) 2009 guidance documents. http://www.who.int (last accessed 8 November 2011).
2. Public Health Agency of Canada. Guidance - H1N1 flu virus. http://www.phac-aspc.gc.ca (last accessed 8 November 2011).
3. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680-689.
4. Centers for Disease Control and Prevention. Neurologic complications associated with novel influenza A (H1N1) virus infection in children - Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep. 2009;58:773-778.
5. Shope RE. The etiology of swine influenza. Science. 1931;73:214-215.
6. Centers for Disease Control and Prevention (CDC). Swine-origin influenza A (H3N2) virus infection in two children: Indiana and Pennsylvania, July-August 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1213-1215.
7. Shinde V, Bridges CB, Uyeki TM, et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med. 2009;360:2616-2625.
8. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-2615.
9. Fraser C, Donnelly CA, Cauchemez S, et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 2009;324:1557-1561.
10. Yang Y, Sugimoto JD, Halloran ME, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science. 2009;326:729-733.
11. Centers for Disease Control and Prevention. 2009 H1N1 early outbreak and disease characteristics.November 2009. http://www.cdc.gov/ (last accessed 8 November 2011).
12. Falagas ME, Cholevas NV, Kapaskelis AM, et al. Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere. Eur J Clin Microbiol Infect Dis. 2010;29:1327-1347.
13. Van Kerkhove MD, Vandemaele KA, Shinde V, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8:e1001053.
14. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374:451-458.
15. Louie JK, Acosta M, Winter K, et al; California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302:1896-902.
16. Centers for Disease Control and Prevention. CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009 – March 13, 2010. April 2010. http://www.cdc.gov (last accessed 8 November 2011).
17. Fowlkes AL, Arguin P, Biggerstaff MS, et al. Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States, April-July 2009. Clin Infect Dis. 2011;52(suppl 1):S60-S68.
18. Chang YS, van Hal SJ, Spencer PM, et al. Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the "PROTECT" phase of the pandemic response. Med J Aust. 2010;192:90-93.
19. McLean E, Pebody RG, Campbell C, et al. Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect. 2010;138:1531-1541.
20. Cao B, Li XW, Mao Y, et al; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361:2507-2517.
21. Centers for Disease Control and Prevention. Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:536-541.
22. Centers for Disease Control and Prevention. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep. 2009;58:749-752.
23. Morgan OW, Bramley A, Fowlkes A, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One. 2010;5:e9694.
24. Díaz E, Rodríguez A, Martin-Loeches I, et al. Impact of obesity in patients infected with 2009 influenza A(H1N1). Chest. 2011;139:382-386.
25. Louie JK, Acosta M, Samuel MC, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis. 2011;52:301-312.
26. Centers for Disease Control and Prevention. Guidance for businesses and employers to plan and respond to the 2009-2010 influenza season. February 2010. http://www.cdc.gov/ (last accessed 8 November 2011).
27. Jefferson T, Del Mar CB, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2011;(7)CD006207.
28. Cowling BJ, Chan KH, Fang VJ, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med. 2009;151:437-446.
29. Loeb M, Dafoe N, Mahony J, et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA. 2009; 302:1865-1871.
30. Centers for Disease Control and Prevention. Prevention strategies for seasonal influenza in health care settings. September 2010. http://www.cdc.gov (last accessed 8 November 2011).
31. Bernstein HH, Starke JR; American Academy of Pediatrics. Policy statement: recommendation for mandatory influenza immunization of all health care personnel. Pediatrics. 2010;126:809-815.
32. Fiore AE, Fry A, Shay D, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60:1-24.
33. Wu J, Li W, Wang HQ, et al. A rapid immune response to 2009 influenza A(H1N1) vaccines in adults: a randomized, double-blind, controlled trial. J Infect Dis. 2010;202:675-680.
34. Weinberg A, Song LY, Walker R, et al. Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children. J Acquir Immune Defic Syndr. 2010;55:189-196.
35. Talbot HK, Keitel W, Cate TR, et al. Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine. 2008;26:4057-4061.
36. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP). August 2011. http://www.cdc.gov (last accessed 8 November 2011).
37. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG committee opinion no. 468: influenza vaccination during pregnancy. Obstet Gynecol. 2010;116:1006-1007.
38. Huss A, Scott P, Stuck AE, et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ. 2009;180:48-58.
39. US Department of Health and Human Services Interagency Public Affairs Group on Influenza Preparedness and Response. Interim guidance for use of 23-valent pneumococcal polysaccharide vaccine during novel influenza A (H1N1) outbreak. October 2009. http://www.cdc.gov/ (last accessed 8 November 2011).
40. Centers for Disease Control and Prevention. Updated recommendations for obstetric health care providers related to use of antiviral medications in the treatment and prevention of influenza for the 2010-2011 season. December 2010. http://www.cdc.gov (last accessed 8 November 2011).
41. Centers for Disease Control and Prevention. Clinical description and laboratory diagnosis of influenza. September 2011. http://www.cdc.gov (last accessed 8 November 2011).
42. World Health Organization. WHO recommendations on the use of rapid testing for influenza diagnosis. July 2005. http://www.who.int/en/ (last accessed 8 November 2011).
43. Lera E, Wörner NT, Sancosmed M, et al. Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital. Eur J Pediatr. 2011;170:371-378.
44. Zenciroglu A, Kundak AA, Aydin M, et al. Swine influenza A (H1N1) virus infection in infants. Eur J Pediatr. 2011;170:333-338.
45. Centers for Disease Control and Prevention. 2009-10 influenza prevention & control recommendations: clinical signs and symptoms of influenza. July 2009. http://www.cdc.gov (last accessed 8 November 2011).
46. Kwong JC, Campitelli MA, Rosella LC. Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis. 2011;53:413-421.
47. Hurt AC, Baas C, Deng YM, et al. Performance of influenza rapid point-of-care tests in the detection of swine lineage A (H1N1) influenza viruses. Influenza Other Respi Viruses. 2009;3:171-176.
48. Faix DJ, Sherman SS, Waterman SH. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;361:728-729.
49. World Health Organization. CDC protocol of realtime RTPCR for influenza A(H1N1). October 2009. http://www.who.int (last accessed 8 November 2011).
50. World Health Organization. WHO information for laboratory diagnosis of new influenza A (H1N1) virus in humans. November 2009. http://www.who.int/en/ (last accessed 8 November 2011).
51. Centers for Disease Control and Prevention (CDC). Swine-origin influenza A (H1N1) virus infections in a school - New York City, April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:470-472.
52. Louie JK, Jean C, Acosta M, et al. A review of adult mortality due to 2009 pandemic (H1N1) influenza A in California. PLoS One. 2011;6:e18221.
53. Falagas ME, Koletsi PK, Baskouta E, et al. Pandemic A(H1N1) 2009 influenza: review of the Southern Hemisphere experience. Epidemiol Infect. 2011;139:27-40.
54. Surana P, Tang S, McDougall M, et al. Neurological complications of pandemic influenza A H1N1 2009 infection: European case series and review. Eur J Pediatr. 2011;170:1007-1015.
55. Babin SM, Hsieh YH, Rothman RE, et al. A meta-analysis of point-of-care laboratory tests in the diagnosis of novel 2009 swine-lineage pandemic influenza A (H1N1). Diagn Microbiol Infect Dis. 2011;69:410-418.
56. Viasus D, Paño-Pardo JR, Pachón J, et al. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A (H1N1) virus infection. Chest. 2011;140:1025-1032.
57. Rodríguez A, Díaz E, Martín-Loeches I, et al. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother. 2011;66:1140-1149.
58. Hiba V, Chowers M, Levi-Vinograd I, et al. Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study. J Antimicrob Chemother. 2011;66:1150-1155.
59. Yu H, Feng Z, Uyeki TM, et al. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis. 2011;52:457-465.
60. Centers for Disease Control and Prevention. Termination of declarations of emergency justifying EUA of certain antiviral drugs: Tamiflu (oseltamivir phosphate), Relenza (zanamivir), and peramivir. June 2010. http://www.cdc.gov/ (last accessed 8 November 2011).
61. Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. September 2009. http://www.cdc.gov (last accessed 8 November 2011).
62. Siedler K, Skopnik H. Oseltamivir for treatment of influenza in infants less than one year: a retrospective analysis. Pediatric Infect Dis J. 2010;29:495-498.
63. Centers for Disease Control and Prevention. Updated interim recommendations for obstetric health care providers related to use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. December 2009. http://www.cdc.gov/ (last accessed 8 November 2011).
64. Moretti ME, Bar-Oz B, Fried S, et al. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology. 2005;16:216-219.
65. World Health Organization. Pandemic (H1N1) 2009 briefing note 1: viruses resistant to oseltamivir (Tamiflu) identified. Wkly Epidemiol Rec. 2009;84:299-399.
66. Hurt AC, Lee RT, Leang SK, et al. Increased detection in Australia and Singapore of a novel influenza A( H1N1) 2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation. Euro Surveill. 2011;16.
67. Thorlund K, Awad T, Boivin G, et al. Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis. 2011;11:134.
68. Longtin J, Patel S, Eshaghi A, et al. Neuraminidase-inhibitor resistance testing for pandemic influenza A (H1N1) 2009 in Ontario, Canada. J Clin Virol. 2011;50:257-261.
69. Mancuso CE, Gabay MP, Steinke LM, et al. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza. Ann Pharmacother. 2010;44:1240-1249.
70. Kohno S, Kida H, Mizuguchi M, et al. Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection. Antimicrob Agents Chemother. 2010;54:4568-4574.
71. Hernandez JE, Adiga R, Armstrong R, et al. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States. Clin Infect Dis. 2011;52:695-706.
72. Harter G, Zimmermann O, Maier L, et al. Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus. Clin Infect Dis. 2010;50:1249-1251.
73. Gaur AH, Bagga B, Barman S, et al. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med. 2010;362:88-89.
74. Davies A, Jones D, Bailey M, et al; Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009;302:1888-1895.
75. Duval X, van der WS, Blanchon T, et al. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med. 2010;7:e1000362.
76. Martin-Loeches I, Lisboa T, Rhodes A, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med. 2011;37:272-283.
77. Brun-Buisson C, Richard JC, Mercat A, et al. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med. 2011;183:1200-1206.
78. Martín-Loeches I, Sanchez-Corral A, Diaz E, et al. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest. 2011;139:555-562.
79. Ramsey C, Kumar A. H1N1: viral pneumonia as a cause of acute respiratory distress syndrome. Curr Opin Crit Care. 2011;17:64-71.
80. Morishima T, Togashi T, Yokota S, et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis. 2002;35:512-517.
81. Amin R, Ford-Jones E, Richardson SE, et al. Acute childhood encephalitis and encephalopathy associated with influenza: a prospective 11-year review. Pediatr Infect Dis J. 2008;27:390-395.
82. Akins PT, Belko J, Uyeki TM, et al. H1N1 encephalitis with malignant edema and review of neurologic complications from influenza. Neurocrit Care. 2010;13:396-406.
83. Baltagi SA, Shoykhet M, Felmet K, et al. Neurological sequelae of 2009 influenza A (H1N1) in children: a case series observed during a pandemic. Pediatr Crit Care Med. 2010;11:179-184.
84. Sperber SJ, Francis JB. Toxic shock syndrome during an influenza outbreak. JAMA. 1987;257:1086-1087.
85. Yang P, Deng Y, Pang X, et al. Severe, critical and fatal cases of 2009 H1N1 influenza in China. J Infect. 2010;61:277-283.
